In a post-pandemic era, the global demand for Infectious Disease Solutions has shifted from reactive emergency response to proactive, high-precision surveillance. At Shenzhen BioX Medical Co., Ltd., we recognize that infectious diseases—ranging from respiratory viruses to blood-borne pathogens—require a multi-tiered diagnostic approach. Our OEM and ODM services provide international partners with the technological backbone to deploy robust testing infrastructures in varied environments.
From the urban hospitals of Europe to decentralized clinics in the Asia-Pacific, the necessity for Molecular Diagnostic Analysis Systems that offer "sample-to-result" automation is paramount. We provide not just equipment, but comprehensive industrial solutions that integrate Digital PCR, Next-Generation Sequencing (NGS) prep, and Automated Biomarker Analysis.
Shenzhen is the global epicenter for medical device innovation. Our facility integrates R&D, electronic component sourcing, and precision plastic molding under one roof, reducing lead times by 40% compared to Western counterparts.
We offer modular hardware designs. Whether you need a 16-well portable PCR for field use or a 96-well high-throughput system for national laboratories, our engineering team provides rapid prototyping and scaling.
Leveraging China's mature supply chain, we deliver premium-tier diagnostic technology at a cost-of-ownership that allows for mass deployment in emerging markets, supporting global health equity.
As a Custom OEM Infectious Disease Solutions Factory, we track several critical trends that are shaping procurement strategies for global enterprises:
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions. Our product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies.
High-throughput PCR systems for routine screening of STIs, Hepatitis, and Tuberculosis in high-density urban hospitals.
Detecting African Swine Fever or Feline Infectious Peritonitis (FIPV) to protect livestock economies and pet health.
Portable, battery-operated diagnostic tools for epidemic monitoring in regions with unstable power grids.
Tailored diagnostic systems for pharmaceutical companies conducting clinical trials on new infectious disease therapeutics.
BioX Medical
